Found: 9
Select item for more details and to access through your institution.
Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease; refractory anemia with ring sideroblasts associated with marked thrombocytosis.
- Published in:
- Canadian Journal of Pathology, 2016, v. 8, p. 34
- By:
- Publication type:
- Article
Final report of TKI discontinuation trial with dasatinib for the second attempt of treatment‐free remission after failing the first attempt with imatinib: Treatment‐free Remission Accomplished by Dasatinib (TRAD) study.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 5, p. 781, doi. 10.1111/bjh.19058
- By:
- Publication type:
- Article
BCR–ABL1 transcript doubling time as a predictor for treatment‐free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 1, p. 136, doi. 10.1111/bjh.17807
- By:
- Publication type:
- Article
Patient‐reported fatigue refines prognosis in higher‐risk myelodysplastic syndromes (MDS): a MDS‐CAN study.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 2, p. 319, doi. 10.1111/bjh.17537
- By:
- Publication type:
- Article
A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab‐refractory iNHL (COMPLEMENT A + B study).
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 6, p. 1123, doi. 10.1111/bjh.17420
- By:
- Publication type:
- Article
Optimal duration of imatinib treatment/deep molecular response for treatment‐free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 4, p. 779, doi. 10.1111/bjh.17447
- By:
- Publication type:
- Article
Overall survival in lower IPSS risk MDS by receipt of iron chelation therapy, adjusting for patient-related factors and measuring from time of first red blood cell transfusion dependence: an MDS- CAN analysis.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 1, p. 83, doi. 10.1111/bjh.14825
- By:
- Publication type:
- Article
A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Management of Marginal Zone Lymphoma: A Canadian Perspective.
- Published in:
- Current Oncology, 2023, v. 30, n. 2, p. 1745, doi. 10.3390/curroncol30020135
- By:
- Publication type:
- Article